PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34054546-14	2021	Furthermore, treatment of naringin attenuated the production of inflammatory cytokines and matrix metalloproteinases (MMPs) in TNF-alpha-induced RA-FLS.	naringin	26-34	matrix metallopeptidase 9	Homo sapiens	118-122	
34054546-17	2021	Naringin inhibits inflammation and MMPs production and promotes apoptosis in RA-FLS via PI3K/Akt and MAPK/ERK signaling pathways.	naringin	0-8	matrix metallopeptidase 9	Homo sapiens	35-39	
26721195-0	2016	Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma.	naringin	0-8	matrix metallopeptidase 9	Homo sapiens	95-100	
26721195-7	2016	Collectively, our data showed that naringin attenuated the MAPK signaling pathways including ERK, JNK and p38 and resulted in the downregulation of the expression and enzymatic activities of MMP-2, MMP-9, contributing to the inhibition of metastasis in U87 cells.	naringin	35-43	matrix metallopeptidase 9	Homo sapiens	198-203	
26474590-0	2016	Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway.	naringin	0-8	matrix metallopeptidase 9	Homo sapiens	104-109	
19810018-3	2009	Naringin inhibited tumor necrosis factor-alpha (TNF-alpha)-induced expression of MMP-9, under 10-25 microM concentration conditions in vascular smooth muscle cells (VSMC).	naringin	0-8	matrix metallopeptidase 9	Homo sapiens	81-86